CNN Underscored recommends Elevai Enfinity serum
The feature highlights exosome technology for hydration, barrier strength, and redness, with dermatologist endorsements for daily use.
See the latest news and media coverage for Elevai. We track all announcements, press releases, and industry mentions in real time, all in one place.
Exosome-based skincare and haircare products
elevaiskincare.comLast updated
In short: Elevai secured a five-year royalty stream from its skincare sale and licensed GLP-1 assets.
The feature highlights exosome technology for hydration, barrier strength, and redness, with dermatologist endorsements for daily use.
The Root Renewal System blends exosome technology and AI-discovered science. Soft launch via medical aesthetics partners starts now, with full launch in January 2025.
The company created Elevai Biosciences and Elevai Skincare to advance aesthetic medicines and improve commercial economics.
This strategic milestone addresses unmet needs in the multi-billion-dollar medical aesthetics market driven by side effects from existing GLP-1 drugs.
Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.
Elevai Skincare creates products using stem cells to restore damaged skin and hair The skincare subsidiary of former Elevai Labs Inc. has been acquired by...
NEWPORT BEACH, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is proud...
NEWPORT BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce...
Track Elevai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.